Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 8 | Moat RossCHIEF OPERATING OFFICER | Open-market sale · 10b5-1 plan | SELL | $80K 1,703 sh |
| Apr 13, 2026 traded Apr 9, 2026 |
| 7 | Howard Justyn RussellDirector, Executive Chair, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 40.0K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 6 | Rodman David MalcomChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $59K 2,170 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 5 | Shetty Reshma P.Director, See remarks, 10% Owner | Option exercise | M | — 251.8K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 5 | Canton Barry10% Owner | Option exercise | M | — 251.8K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 5 | Renninger RobertCHIEF FINANCIAL OFFICER | Grant or award | A | — 300.0K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 5 | Freemen-Bosworth LaurenEVP/Gen Counsel & Corp Sec | Open-market sale · 10b5-1 plan | SELL | $7,970 693 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 5 | Pomel OlivierDirector, Chief Executive Officer | Option exercise · 10b5-1 plan | M | $384K 35.7K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 4 | Pelish Henry E.Chief Scientific Officer | Option exercise · 10b5-1 plan | M | — 3,093 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 4 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | — 14.7K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 4 | Perducat CyrilSVP, Chief Technology Officer | Option exercise · 10b5-1 plan | M | — 581 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 3 | Erlinger Joseph M.President, McDonald's USA | Option exercise · 10b5-1 plan | M | — 2,626 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 3 | Pomel OlivierDirector, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 42.4K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 3 | Pomel OlivierDirector, Chief Executive Officer | Option exercise · 10b5-1 plan | M | — 38.1K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 2 | Yuan Eric S.Director, Chief Executive Officer | Grant or award | A | — 561.6K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 1 | Rosenbaum Michael GeorgeDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $143K 1,200 sh | Apr 13, 2026 traded Apr 13, 2026 |
| 1 | Cook MeredithSR. VP, GENERAL COUNSEL & SEC. | Open-market sale · 10b5-1 plan | SELL | $39K 500 sh | Apr 13, 2026 traded Apr 13, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | $35K 2,170 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | — 2,170 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 0 | Nagendran SukumarDirector, President and Head of R&D | Option exercise · 10b5-1 plan | M | — 19.0K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | $56K 6,613 sh | Apr 13, 2026 traded Apr 13, 2026 |
| 0 | Pelish Henry E.Chief Scientific Officer | Option exercise · 10b5-1 plan | M | $86K 3,093 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | $107K 14.7K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | $59K 8,109 sh | Apr 13, 2026 traded Apr 13, 2026 |
| 0 | Tan Anthony Ping YeowDirector, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 800.0K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 0 | Pomel OlivierDirector, Chief Executive Officer | Option exercise · 10b5-1 plan | M | $35K 38.1K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 0 | Pomel OlivierDirector, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 42.4K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | — 14.7K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 0 | Chang MichelleChief Financial Officer | Option exercise · 10b5-1 plan | M | — 0 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 0 | Perducat CyrilSVP, Chief Technology Officer | Option exercise · 10b5-1 plan | M | — 581 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | $107K 14.7K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 0 | Nagendran SukumarDirector, President and Head of R&D | Option exercise · 10b5-1 plan | M | $33K 19.0K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | — 6,613 sh | Apr 13, 2026 traded Apr 13, 2026 |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | — 8,109 sh | Apr 13, 2026 traded Apr 13, 2026 |
| 0 | Howard Justyn RussellDirector, Executive Chair, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 40.0K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 0 | Pomel OlivierDirector, Chief Executive Officer | Option exercise · 10b5-1 plan | M | — 35.7K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 56 | George GregoryDirector, 10% Owner | Open-market purchase | BUY | $5.68M 4.00M sh | Apr 10, 2026 traded Apr 4, 2026 |
| 51 | Page JustineDirector | Open-market sale | SELL | $712K 2,018 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 51 | Velaga S. RamPresident, ISG | Open-market sale | SELL | $6.08M 17.3K sh | Apr 10, 2026 traded Apr 9, 2026 |
| 50 | Kawwas Charlie BPresident, SSG | Open-market sale | SELL | $3.45M 10.0K sh | Apr 10, 2026 traded Apr 8, 2026 |